IBJNews

'12 worst year for life sciences since 1990s

Back to TopCommentsE-mailPrintBookmark and Share

To understand why Indiana’s life sciences entrepreneurs are frustrated with the flow of venture capital, look no further than this statistic from a recent PricewaterhouseCoopers report: 2012 was the slowest year for first-time life sciences investment since 1995.

Nationwide, venture capital deals for life sciences companies totaled 779 last year, down 7 percent from 2011. Total investment came to $6.6 billion, a 14-percent decline from the year before. That was the lowest level of life sciences investment since 1998.

Indiana generally followed those trends, with life sciences deals falling to five in 2012 from six the year before. Total life sciences investment in the state fell 11 percent, to $24.2 million.

“As the number of new funds being raised continues to shrink, venture capitalists are being more discriminating with where they’re willing to place new bets,” Tracy T. Lefteroff, global managing partner of the venture capital practice at Pricewaterhouse, said in a report issued this month. “At the same time, they’re holding on to reserves to continue to support the companies already in their portfolio. Both factors are taking a toll on the amount of capital available for young startups, which is reflected in a 38-percent drop in the number of seed-stage companies receiving VC dollars in 2012.” 

Steve Hourigan, president of Elevate Ventures in Indianapolis, said those trends have made it nearly impossible for his organization to find co-investment partners on early-stage life sciences companies.

Elevate manages the Indiana 21st Century Research & Technology Fund on contract with the state. The organization has been criticized by life sciences entrepreneurs for backing away from life sciences companies in favor of IT and other kinds of businesses.

Indiana continues to run significantly behind its Midwestern neighbors in total life sciences venture capital raised.

Minnesota, typically the Midwest’s behemoth for life sciences companies, recorded 14 deals last year for a total of $138.9 million. Those totals were well below the state’s 2011 performance, when 28 companies attracted $220.8 million in life sciences venture capital.

The number of deals also slipped in Ohio, to 31 last year from 35 the year before. But total life sciences venture capital shot up 97 percent to $181.9 million.

Michigan also saw big gains, with 27 companies attracting $97.7 million last year, up from 11 deals the previous year that attracted $27.9 million.

In Illinois, the number of deals dropped to 10 last year from 15 the previous year. But those 10 deals brought in $165.8 million, a 17-percent increase from 2011.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. If I were a developer I would be looking at the Fountain Square and Fletcher Place neighborhoods instead of Broad Ripple. I would avoid the dysfunctional BRVA with all of their headaches. It's like deciding between a Blackberry or an iPhone 5s smartphone. BR is greatly in need of updates. It has become stale and outdated. Whereas Fountain Square, Fletcher Place and Mass Ave have become the "new" Broad Ripples. Every time I see people on the strip in BR on the weekend I want to ask them, "How is it you are not familiar with Fountain Square or Mass Ave? You have choices and you choose BR?" Long vacant storefronts like the old Scholar's Inn Bake House and ZA, both on prominent corners, hurt the village's image. Many business on the strip could use updated facades. Cigarette butt covered sidewalks and graffiti covered walls don't help either. The whole strip just looks like it needs to be power washed. I know there is more to the BRV than the 700-1100 blocks of Broad Ripple Ave, but that is what people see when they think of BR. It will always be a nice place live, but is quickly becoming a not-so-nice place to visit.

  2. I sure hope so and would gladly join a law suit against them. They flat out rob people and their little punk scam artist telephone losers actually enjoy it. I would love to run into one of them some day!!

  3. Biggest scam ever!! Took 307 out of my bank ac count. Never received a single call! They prey on new small business and flat out rob them! Do not sign up with these thieves. I filed a complaint with the ftc. I suggest doing the same ic they robbed you too.

  4. Woohoo! We're #200!!! Absolutely disgusting. Bring on the congestion. Indianapolis NEEDS it.

  5. So Westfield invested about $30M in developing Grand Park and attendance to date is good enough that local hotel can't meet the demand. Carmel invested $180M in the Palladium - which generates zero hotel demand for its casino acts. Which Mayor made the better decision?

ADVERTISEMENT